Financials

  • Market Capitalization 638.98 M
  • Employee 808
  • Founded 2006
  • CEO Timothy R Wright
  • Website www.mimedx.com
  • Headquarter Georgia, United States
  • FIGI BBG000RJ6FL5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.75
Price to sales ratio
1.52

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2698
MNPR
Monopar Therapeutics Inc. - Common Stock
108.76 USD+8.99%+9.56%+79.44%+99.12%728.59 M USD
2718
BBOT
BridgeBio Oncology Therapeutics, Inc. - Common Stock
8.41 USD-4.65%-6.76%+8.24%-11.38%673.70 M USD
2740
PTCT
PTC Therapeutics, Inc. - Common Stock
78.84 USD+1.00%-10.99%+4.56%+64.83%653.97 M USD
2746
RLMD
Relmada Therapeutics, Inc. - Common Stock
6.20 USD-0.16%-3.28%-2.67%+884.13%650.32 M USD

Frequently asked questions about MiMedx Group, Inc - Common Stock

What is the MiMedx Group, Inc - Common Stock stock price today?

The current price of MiMedx Group, Inc - Common Stock (MDXG) is 4.29. Over the past 24 hours, the stock has changed by +2.14%. Follow the MDXG chart for real-time price dynamics.

What is the stock ticker of MiMedx Group, Inc - Common Stock?

MiMedx Group, Inc - Common Stock trades under the ticker MDXG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is MiMedx Group, Inc - Common Stock stock going up?

MDXG has changed by +0.70% over the last week, +16.58% over the last month, and -32.23% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was MiMedx Group, Inc - Common Stock net income for the last quarter?

MiMedx Group, Inc - Common Stock reported net income of -10.86 M for the last quarter. The previous quarter showed 15.19 M, which means net income changed by -171.50%.

How many employees does MiMedx Group, Inc - Common Stock have?

As of the latest available data, MiMedx Group, Inc - Common Stock has 808 employees. Workforce size can provide additional context about the company's scale and operations.

What is MiMedx Group, Inc - Common Stock EBITDA?

MiMedx Group, Inc - Common Stock EBITDA is -16.68 M, and its EBITDA margin is -28.28%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy MiMedx Group, Inc - Common Stock stock?

You can buy MiMedx Group, Inc - Common Stock (MDXG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in MiMedx Group, Inc - Common Stock stock?

Investing in MiMedx Group, Inc - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MDXG chart and related analysis on metatrader.com as part of your research.

News